Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
A Phase 1, Open-label, Single-dose, Dose-escalation, Safety, Tolerability, and PK Study of Intravitreal ANX007 in Participants With Primary Open-angle Glaucoma
Status: Enrolling
Updated:  12/31/1969
mi
from
Palo Alto, CA
Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
A Phase 1, Open-label, Single-dose, Dose-escalation, Safety, Tolerability, and PK Study of Intravitreal ANX007 in Participants With Primary Open-angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Byers Eye Institute at Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Andover, MA
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Cornea Consultants of Arizon
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Sacramento, CA
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Eye Site Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Torrance, CA
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
East West Eye Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Havre de Grace, MD
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Seidenberg Protzko Eye Associates
mi
from
Havre de Grace, MD
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Eye Clinics of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
R&R Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Edgewood, KY
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute-Edgewood
mi
from
Edgewood, KY
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Garden City, NY
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
mi
from
Garden City, NY
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Mount Pleasant, SC
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Kerry Solomon, MD
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated:  12/31/1969
mi
from
Charlotte, NC
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated:  12/31/1969
mi
from
Statesville, NC
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose & Throat Associates, P.A.
mi
from
Statesville, NC
Click here to add this to my saved trials
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Status: Enrolling
Updated:  12/31/1969
mi
from
Ann Arbor, MI
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100
Pilot Comparative Study of the Kowa OCT Bi-μ and the Optovue iVue 100
Status: Enrolling
Updated:  12/31/1969
mi
from
Andover, MA
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100
Pilot Comparative Study of the Kowa OCT Bi-μ and the Optovue iVue 100
Status: Enrolling
Updated: 12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Optimizing the Ocular Surface Prior to Cataract Surgery
Optimizing the Ocular Surface Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Norfolk, VA
Optimizing the Ocular Surface Prior to Cataract Surgery
Optimizing the Ocular Surface Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium
Status: Enrolling
Updated:  12/31/1969
mi
from
Laguna Beach, CA
Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium
Status: Enrolling
Updated: 12/31/1969
Harvard Eye Associates
mi
from
Laguna Beach, CA
Click here to add this to my saved trials
Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)
A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD
Status: Enrolling
Updated:  12/31/1969
mi
from
San Diego, CA
Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)
A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD
Status: Enrolling
Updated: 12/31/1969
Valeant Site 11
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated:  12/31/1969
mi
from
Jacksonville, FL
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Dr. James Weber & Associates, PA
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated:  12/31/1969
mi
from
Jacksonville, FL
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Vue Optical Boutique
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated:  12/31/1969
mi
from
East Lansing, MI
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
VisionCare Associates
mi
from
East Lansing, MI
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated:  12/31/1969
mi
from
Pickens, SC
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Pickens Family Eye Care
mi
from
Pickens, SC
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated:  12/31/1969
mi
from
Salt Lake City, UT
Evaluation of Approved and Investigational Contact Lenses
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
William J. Bogus, OD
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
mi
from
Brea, CA
mi
from
Brea, CA
Click here to add this to my saved trials
mi
from
Campbell, CA
Clinical Research Facility
mi
from
Campbell, CA
Click here to add this to my saved trials
mi
from
Cupertino, CA
mi
from
Cupertino, CA
Click here to add this to my saved trials
mi
from
Mission Viejo, CA
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
mi
from
Colorado Springs, CO
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
mi
from
Bridgeport, CT
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
mi
from
Aventura, FL
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
mi
from
Jacksonville, FL
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
mi
from
Tallahassee, FL
Clinical Research Facility
mi
from
Tallahassee, FL
Click here to add this to my saved trials
mi
from
Tampa, FL
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
mi
from
Winter Park, FL
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
mi
from
Roswell, GA
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
mi
from
Bloomington, IL
Clinical Research Facility
mi
from
Bloomington, IL
Click here to add this to my saved trials
mi
from
Mishawaka, IN
Clinical Research Facility
mi
from
Mishawaka, IN
Click here to add this to my saved trials
mi
from
Pittsburg, KA
Clinical Research Facility
mi
from
Pittsburg, KA
Click here to add this to my saved trials
mi
from
Boston, MA
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
mi
from
Independence, MO
Clinical Research Facility
mi
from
Independence, MO
Click here to add this to my saved trials
mi
from
Raytown, MO
mi
from
Raytown, MO
Click here to add this to my saved trials
mi
from
Closter, NJ
mi
from
Closter, NJ
Click here to add this to my saved trials
mi
from
New York, NY
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
mi
from
Raleigh, NC
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
mi
from
North Olmsted, OH
mi
from
North Olmsted, OH
Click here to add this to my saved trials
mi
from
Powell, OH
mi
from
Powell, OH
Click here to add this to my saved trials
mi
from
Kittanning, PA
Clinical Research Facility
mi
from
Kittanning, PA
Click here to add this to my saved trials
mi
from
Warwick, RI
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
mi
from
Chamberlain, SD
mi
from
Chamberlain, SD
Click here to add this to my saved trials
mi
from
Bartlett, TN
Clinical Research Facility
mi
from
Bartlett, TN
Click here to add this to my saved trials